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THORACIC SURGERY PREPARATION, PATIENT ELECTION, AND ITS 
MANAGEMENT DURING COVID-19 PANDEMIC: SURABAYA EXPERIENCES 
 




 A novel coronavirus pneumonia outbreak began in Wuhan, Hubei Province, in December 
2019. It has spread rapidly from China to worldwide. The COVID-19 pandemic of 2020 posed a 
historic challenge to healthcare systems around the world, healthcare systems needed to consider 
providing clinical services to other patients in need. The specialty of general thoracic surgery 
includes the management of serious diseases such as chest wall congenital anomaly, lung cancers, 
esophageal cancers, mediastinal tumor, chest wall infection, and trauma. Thoracic surgery is one of 
high risk procedure in this pandemic, however, a high level of evidence supports the surgical 
management of potential patients with thoracic disease and anomaly is still lacking. Critical 
determinants of robust thoracic surgery service provision are pre-existing plans for epidemic 
response. "Flatten the curve" as an aggressive action is needed. Prioritizations of thoracic surgery 
cases are needed to differ between elective and emergency cases to limit any contamination. Before 
surgery, important pre-operative assessments were conducted aims to identify patients' high risk 
and adjust the procedure. example of a recommendation, if urgent / emergency surgery with 
symptoms clear clinical pneumonia or rapid test (+).  The lessons learned can apply to the other 
areas during this pandemic, and the world, in preparation for the next one. 
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The first case of 2019 coronavirus 
disease (COVID-19) caused by the SARS 
Coronavirus 2 (SARS-CoV-2) was reported 
in Wuhan, China, precisely around December 
2019. It has spread rapidly from China to 
worldwide.1 According to J. Wang et al., 
Human to human transmission of SARS-
CoV-2 was established. It has caused 
coronavirus disease (COVID-19) in over 
90,000 people in 72 countries, with a case 
fatality rate of 2.3% in China and 1.6% 
outside China.2 In Indonesia, on July 13, 
2020, Indonesia has reported 76.981 
confirmed cases of COVID-19, the highest in 
Southeast Asia. In terms of dead patient 
numbers, Indonesia ranks sixth in Asia, with 
3.656 deaths with a case fatality rate of 4,7 
%.3 Coronaviruses are single-stranded RNA 
viruses that are classified into four types. 
SARS-CoV-2, as well as the previously 
characterized SARS-CoV, which caused the 
2003 SARS pandemic, belongs to the genus 
of beta coronaviruses.4 These viruses show 
82% homology in their genomic sequences 
and attach to host cells through their spike 
proteins (SARS-2-S and SARS-S, 
respectively) binding to angiotensin-
converting enzyme 2 (ACE2) as a receptor. 
Viral fusion with the host cell and then 
infection follows as a result of cellular 
cysteine and serine protease-mediated 
cleavage of SARS-2-S and SARS.5, 6 The 
clinical manifestation of SARS-CoV-2  
 
 
infection is mostly characterized by 
respiratory tract symptoms, included fever, 
dry cough, dyspnea, myalgia, fatigue, and 
radiographic evidence of pneumonia. Those 
clinical manifestations can cause 
complications such as pneumonia and acute 
respiratory distress syndrome.7, 1 
 This virus that caused COVID-19 
pandemic has stricken many people, taken 
many lives, and devastated economies around 
the world on a massive scale. It has 
challenged healthcare services worldwide, as 
human and material resources were mobilized 
to combat the surging pandemic.8 To bend the 
epidemic curve downwards, we must prevent 
50−70% of possible transmissions. The key 
points to counter the problem of COVID-19 
are isolation of cases, and precautionary self-
isolation of contacts, the COVID-19 
experience from other countries showed that 
forcefully. Following a positive test result, 
that person should be isolated to prevent 
onward transmission.9 In Indonesia, the 
Medical Association Indonesian General 
Surgery Specialist (PABI) has also published 
work guidelines for all members of PABI 
within performing surgical services, including 
restrictions on visits to the surgical clinic and 
surgery postponed. Before surgery, important 
pre-operative assessments were conducted 
aims to identify patients' high risk and adjust 
the procedure. example of a recommendation, 
if urgent / emergency surgery with symptoms  
 




clear clinical pneumonia or rapid test (+), 
patients treated as a patient with supervision 
use of PPE level 3.10,11 
The specialty of general thoracic 
surgery includes the management of serious 
diseases such as chest wall congenital 
anomaly, lung cancers, esophageal cancers, 
mediastinal tumor, chest wall infection, and 
trauma. Time is fundamental in the successful 
management of these diseases. Therefore, it is 
a clinical and ethical necessity to provide 
adequate care for patients with thoracic 
surgical conditions, even during the COVID-
19 pandemic.8 The urgency of surgical 
treatment for such malignancies is arguably 
greater than in other surgical specialties 
where elective surgery can be postponed. At 
the same time, an emergency case surgery 
remains served in the emergency room as a 
case emergency state.  It is, therefore, a 
clinical and ethical challenge to provide 
adequate surgical care for patients with a 
congenital thoracic anomaly, thoracic cancer, 
thoracic infection that require surgical 
intervention, thoracic trauma in the face of 
stretched resources during the ongoing 
COVID-19 pandemic.12 In conclusion, 
following the agreed surgical protocol and  
 
 
surgical strategy will provide the best services 
for patients while protecting medical officers 
in the COVID-19 pandemic era. Currently, 
only a few recommendations guidelines have 
been made on the preparation of perioperative 
environments to support prompt care to 
cardiothoracic surgery in times of COVID-19 
in Indonesia. This article was made to help 
cardiothoracic surgeons in Indonesia and all 
around the world to overcome the COVID-19 
challenge, especially in thoracic surgery 
fields. 
2. THORACIC SURGERY TRIAGE 3 
PHASES SCENARIO DURING 
COVID-19 PANDEMIC  
2.1 Phase 1  
  In this phase, surgery is indicated for 
patients whose survival rate likely to be not 
compromised by a surgical delay of three 
months. In Indonesia, only a few amount of 
COVID-19-infected patients that went to the 
hospital. The hospital resources are still 
capable, with no rapid escalation moment in 
COVID-19 trajectory. ICU ventilator capacity 
is available to support whether any 
complications that need ventilator support 
such as respiratory failures occurred after 
thoracic surgery. Patients that likely to require 
prolonged ICU needs (high-risk patients) are 
recommended to be deferred.13  













Table 1. Thoracic Surgery Triage in Phase 1 (Adopted and modified from  COVID-19 Guidance for Triage 
Operation for Thoracic Malignancies13) 
THORACIC DISEASE TO OPERATE NOT TO OPERATE 
Congenital Anomaly • Recurrent Pneumonitis in 
Congenital Tracheoesophageal 
Fistula  
• The congenital diaphragmatic 
anomaly with respiratory distress 
complication and strangulation 
• Cyanosis, Respiratory Distress, 
tension pneumothorax that caused 
by all types of congenital 
pulmonary anomaly 
• All congenital anomaly with a 
further immediate potential life-
threatening complication 
• Elective surgery in all 
types of congenital 
pulmonary anomaly 
• Elective surgery in 
congenital tracheal 
anomaly 
• Elective surgery in 
tracheoesophageal fistula 
with no complication 
• Elective surgery in 
congenital diaphragmatic 
anomaly 
• Pectus Surgery 
Infection • Various kinds of thoracic disease 
with sepsis cannot be treated with 
non-surgical treatment (empyema, 
mediastinitis, osteomyelitis, 
abscess) with stable or unstable 
hemodynamic 
• Massive hemoptysis with unstable 
hemodynamic  
• Recurrent hemoptysis and lung 
fibrotic in Tuberculosis infection 
• Bronchiectasis 
• All type of disease in the 
thoracic cavity that can be 
treated with non-surgical 
treatment 
Malignancy • Malignant Lung cancer with solid 
or predominantly solid (>50%) or 
presumed lung cancer  ≥ 2 cm, 
clinical node-negative  
• Post inductive therapy cancer 
• Esophageal cancer T1b or greater 
• Stenting for esophageal tumor 
• Chest wall tumor of high malignant 
potential not manageable by 
alternative therapy 
• Symptomatic mediastinal tumor- 
diagnosis not amenable with needle 
biopsy 
• Staging to start treatment 
(mediastinoscopy, VATS, Pleural 
dissemination) 
• Esophageal cancer that 
can be managed 
endoscopically 
• Chest Wall Tumor of high 
malignant that potentially 
manageable with 
alternative therapy 
• Thymoma (non-bulky, 
asymptomatic) 








2.2 Phase II 
 In this phase, surgery is indicated for 
patients whose survival rate is not 
compromised if surgery not performed within 
the next few days. In Indonesia, there are 
many COVID-19 patients in the hospital with 
limited resources such as ICU beds 
ventilators, clinicians, and Personal Protective 
Equipment (PPE).8 COVID-19 trajectory 
within hospitals is in a rapidly escalating 
phase. All thoracic procedures typically 
scheduled as routine/elective, are deferred.13  









Table 2. Thoracic Surgery Triage in Phase 2 (Adopted and modified from  COVID-19 Guidance for Triage 
Operation for Thoracic Malignancies13) 
THORACIC DISEASE TO OPERATE NOT TO OPERATE 
Congenital Anomaly • Recurrent Pneumonitis in 
Congenital Tracheoesophageal 
Fistula  
• The congenital diaphragmatic 
anomaly with respiratory distress 
complication and strangulation 
• Cyanosis, Respiratory Distress, 
tension pneumothorax that caused 
by all types of congenital 
pulmonary anomaly 
• Elective surgery of all 
kinds of a congenital 
pulmonary defect with no 
complication 
• Elective surgery in 
congenital tracheal defect 
with no complication 
• Elective surgery in 
tracheoesophageal fistula 
with no complication 
• Elective surgery in 
congenital diaphragmatic 
anomaly 
• Pectus Surgery 
Infection • All type of thoracic infection with 
sepsis, cannot be treated with non-
surgical treatment with unstable 
hemodynamic  
• Bronchiectasis 
• Post-operative minor 
wound infection 
• All kind of infection in 
the thoracic cavity that 
can be treated with non-
surgical treatment 
• The thoracic disease that 
can be drained by chest 
tube 
• Pneumothorax for 
pleurodesis 
Malignancy • Lung cancer-associated infection-
compromising but not septic 
• Lung cancer-associated with 
hemorrhage not amenable to non-
surgical treatment 
• Lung cancer with threatened airway 
• Septic and non-septic perforation in 
esophageal cancer 
• As phase 1 to any non -
complicated lung cancer 
by infection or 
hemorrhage or airway 
obstruction 
• non-malignant pleural 
effusion 
Trauma • All thoracic trauma cases with a 
life-threatening condition (e.g., 
significant airway injury, airway 
obstruction by an inhaled foreign 
body,   pneumothorax, flail chest, 
penetrating chest injury, massive 
hemothorax) 
• Retained bullets with fear of 
migration and embolization 
• All thoracic trauma cases 
that can be treated 
conservatively 
• Retained bullet with no 
fear of migration and 
embolization 
 
2.3 Phase III 
 In this phase, surgery is indicated for 
patients whose survival rates are not 
compromised if surgery not performed within 
the next few hours. Hospital resources are 
critically limited and predominately routed to 
COVID-19 patients. All non-emergent 
operations are deferred.										
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			Table 3. Thoracic Surgery Triage in Phase 3 (Adopted and modified from COVID-19 Guidance for Triage 
Operation for Thoracic Malignancies13) 
THORACIC DISEASE TO OPERATE NOT TO OPERATE 
Congenital Anomaly • All types of congenital anomaly 
with immediate life-threatening 
condition complications 
• All kinds of a congenital 
anomaly with no 
immediate life-threatening 
condition complications 
Infection • All thoracic type of disease with an 
immediately life-threatening 
condition that can not be treated 
with a non-surgical approach 
• All kind of thoracic that 
can be treated with a non-
surgical approach 
Malignancy • Lung Cancer with threatened 
airway 
• Lung Cancer with tumor-associated 
infection 
• Lung cancer with tumor-associated 
hemorrhage and hemodynamically 
unstable 
• Esophageal cancer with septic 
perforation 
• All types of cancer with 
no life-threatening 
condition 
Trauma • All thoracic trauma cases with a 
life-threatening condition (e.g., 
significant airway injury, airway 
obstruction by an inhaled foreign 
body,   pneumothorax, flail chest, 
penetrating chest injury, massive 
hemothorax) 
• All thoracic trauma cases 
that can be treated 
conservatively 




3. SURGERY PREPARATION 
3.1 Patient Screening  
 Most of the thoracic surgical cases are 
performed for a prognostic reason. The 
procedure's timing will depend on between 
patient's benefit and risk of getting infected 
by COVID-19, resource availability, and 
hospital rules. Surgical services for patients 
with thoracic problems (congenital anomaly, 
infection, benign and malignant tumor, 
trauma) were maintained to different 
procedures/protocols across various countries, 
ranging from significant reductions to near-
normal service depends on many COVID-19 
cases. Strict and precise protocols are needed 
to protect medical personnel from exposure to 
the COVID-19 virus during the thoracic 
surgery process. This protocol is important, 
especially in emergency cases requiring 
immediate action, without prior knowledge of 
the patient's medical history. Table 4 shows a 
scoring system that can be used in patients 
with a high degree of urgency (without 
waiting for rapid test results in advance) to 
determine the suspicion of COVID-19, which 
will be associated with surgical preparation. 
Figure 1 shows the flow of surgical decision 
making in an emergency or elective patients 
who have confirmed positive COVID-19 
through rapid tests.10,12,14 





Figure 1. Screening Protocol for Elective and 
Emergency Surgery in Confirmed COVID-19 
Patient (Adapted and modified from Adihusada 
Private Hospital Surabaya)
Table 4. Scoring System for Surgery Preparation (Adapted and Modified from Adihusada Private Hospital 
Surabaya) 
PARAMETERS ASSESSMENT SCORE* 
Pneumonia on CT Scan Exist 5 
Contact history with COVID-19 
positive patient 
Exist 5 
Fever / History of fever in the past 14 
days 
Exist 3 
Desaturation SpO2 ≤95% without oxygen 
supplementation  
3 
AGE ≥44 years old 1 
Gender Male 1 
Respiratory disorder symptoms 
(cough, runny nose, blown, etc.) 
≥ one symptom  1 
Neutrophil – lymphocyte ratio ≥3,13 1 
Total  
Total Score >10 à 3rd level Personal Protective Equipment (PPE)         Lab test: Complete blood, CRP, Rapid test 
 
3.2 Anesthesia Preparation  
In managing patients with confirmed or 
suspected COVID-19 infection, of course, 
planned in conjunction with protection for the 
health care workers. All medical practitioner 
must be provided with personal protective 
equipment (PPE) to prevent droplet and 
contact infections. Before patient treatment, 
the practitioner must identify and review the 
hospital procedural protocols, and plan for 
patient transfer, anesthesia work environment, 
and anesthesia methods.15 The COVID-19 
pandemic does not eliminate cardiothoracic 
cancer and cardiothoracic trauma surgery. 
There is a possibility of unavoidable 
intraoperative aerosol-generating procedures 
in the routine provision of thoracic anesthesia. 
Suggestions for increased severity of illness 
for those exposed to high viral loads have 
been given, and aerosol-generating 
procedures are concerning those involved 
with airway management. There are special 
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condition to consider in terms of lung 
isolation, which require great attention to 
reduce the risk of aerosol generation.16 
Aerosol-generating procedures encountered 
routinely in thoracic anesthesia include: bag-
valve-mask ventilation, tracheal intubation, 
tracheal tube repositioning, bronchoscopy; 
one-lung ventilation, suction clearance of 
secretions, and the management of hypoxia 
during one-lung ventilation.17 
3.2.1 Tracheal Intubation 
The patient should be adequately pre-
oxygenated for 3 min or until the end-tidal 
oxygen fraction is greater than 0.9. The target 
is to achieve sufficient apneic time to allow 
safe intubation without the need for bag-
valve-mask ventilation.18 A modified rapid 
sequence tracheal intubation using high dose 
rocuronium is a must for the anesthetic 
technique. Facemask ventilation should be 
avoided where possible, and a two-person 
technique should be used where necessary. 
Tracheal intubation should be followed 
immediately by cuff inflation, circuit 
connection, and ventilation of both lungs.16 
Confirmation in terms of the position of 
double-lumen tubes involves the use of a 
flexible bronchoscope to visualize the 
endobronchial cuff and its relation to the 
carina directly. If there is a clinical preference 
to avoid bronchoscopy, it is possible to 
perform clinical confirmation of positioning, 
thus preventing disconnection of the 
breathing circuit.17  
Following tracheal intubation with a 
left-sided double-lumen tube, clinical 
confirmation should start with no clamp 
applied and bilateral air entry confirmed with 
manual ventilation. As soon as the two-way 
air entry is achieved, a clamp should be 
applied to the angle piece supplying the 
tracheal lumen. If the double-lumen tube is 
positioned correctly, there should be left-
sided air entry only. If bilateral ventilation 
extends, the distal end of the tracheal tube or 
the bronchial cuff is above the carina, then, 
deflate only the bronchial cuff and advance 
the tracheal tube until there is resistance, re-
inflate the bronchial cuff and repeat the steps 
above. Bronchoscopy will be required to 
troubleshoot placement if there is resistance 
to advancing the tracheal tube or if it is still 
not possible to confirm the correct placement 
clinically. When the tracheal tube is placed 
correctly, the patient should be positioned for 
surgery. The checking process should be 
repeated after positioning laterally to ensure 
the tracheal tube position has not changed.17 
 




Figure 2. Mannequin images demonstrating   
(a) the clamp applied to tracheal lumen angle piece and double-lumen tube; (b) disconnection without pollution; 
(c) using a HEPA viral filter to tracheal lumen; (d) removing the clamp to allow positive pressure from the lung 
to vent through HEPA viral filter; and (e) removing the HEPA viral filter and performing bronchoscopy.17 
 
3.2.2 Lung Isolation 
Some measures can attain lung 
isolation. Left or right-sided double-lumen 
tubes (DLT), bronchial blockers (BB), or a 
single lumen tube (SLT) advanced into the 
non-operative lung are the options. The 
European Association of Cardiothoracic 
Anaesthesiology (EACTA) has announced 
recommendations for airway management in 
thoracic anesthesia.  A survey conducted by 
EACTA showed that lung isolation 
management options are likely to be affected 
by the intubation status of the patient, 
predicted airway difficulty, and individual 
preference.19 The main threat of 
environmental contamination, once the 
airway is secured and with surgery underway, 
is the disconnection of the lumen of the non-
dependent lung. This can be mitigated against 
by allowing the lung to deflate through a 
high-efficiency particulate air (HEPA) viral 
filter. Furthermore, the continued application 
of a HEPA viral filter to the open lumen will  
 
protect against any perioperative loss of lung 
isolation. A leak of any ventilated gas into the 
open lumen causes environmental pollution 
and contamination. The patient should be 
immediately positioned, surgery commenced, 
and lung isolation required. The 
neuromuscular blockade should be adequate. 
The adjustable pressure-limiting valve open 
and ventilation discontinued before the 
surgical lumen of the double-lumen tube and 
the arm of the angle piece serving this lumen 
are clamped. The arm of the angle piece 
should be disconnected, and a HEPA viral 
filter applied to the double-lumen tube's 
surgical lumen. The clamp is then removed 
from the double-lumen tube's surgical lumen 
to facilitate the collapse of the non-dependent 
lung through the HEPA viral filter.17 
3.2.3 One Lung Ventilation 
Another option is to confirm lung 
ventilation with ultrasound, looking for lung 
sliding (ventilation) and absence of lung 
sliding and lung pulse (no ventilation but no 
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pneumothorax).19 For these 
recommendations, it is assumed that all other 
measures to address hypoxia have been 
considered, and the diagnosis is that of shunt-
driven hypoxia. Although two-lung 
ventilation is always the default position for 
critical hypoxia during one-lung ventilation, 
shunt-driven hypoxia can often be overcome 
by administering oxygen to the non-
dependent lung.20 The simplest method of 
administering oxygen to the operative lung is 
via insufflation through a suction catheter 
through the double-lumen tube's open 
lumen.21 This nevertheless carries an 
unacceptable risk of aerosol generation. 
Instead, using a continuous positive airway 
pressure circuit with a HEPA viral filter is the 
recommended method. Standard practice, 
constant positive airway pressure should be 
titrated until there is clinical improvement.17 
 
 
Figure 3. Mannequin images demonstrating 
(a) HEPA viral filter in place on the double-lumen tube's surgical lumen and (b) a continuous positive airway 
pressure circuit safely applied.17 
3.3 Personal Protective Equipment 
 Personal protective equipment 
(PPE) is a device designed as a barrier against 
the penetration of substances, solid particles, 
liquid, or air to protect the wearer from injury 
or spread of infection or disease. When 
appropriately used, PPE acts as a barrier 
between infectious material (e.g., viruses and 
bacteria) and the skin, mouth, nose, or eyes 
(mucous membranes) of health workers and 
patients.22,23 Barriers have the potential to 
block the transmission of contaminants from 
blood, body fluids, or respiratory secretions. 
Effective use of PPE involves the removal 
and/or disposal of PPE that is adequately 
contaminated to prevent the exposure of users 
and others to infectious material. In selecting 
the correct PPE, it is necessary to identify the 
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potential exposure to infectiousness and 
understand the basis for each type of PPE 
work that will be used in the workplace where 
the potential danger threatens healthcare 
workers in the hospital. All PPE used must 
comply with applicable consensus 
standards.2,22 
 Thoracic surgery is a high-risk 
procedure. Asymptomatic patients without a 
confirmed negative COVID-19 Rapid Test - 
PCR test within four days undergoing 
thoracic surgery, all team members must don 
full contact, droplet, and airborne PPE (N95 
respirator with face shield/goggles or PAPR 
plus gown and double gloves) for the entire 
duration of the case. For asymptomatic 
patients with a confirmed negative COVID-
19 RT-PCR test obtained within four days of 
the procedure, standard PPE and pre-COVID 
workflows can be used for any type of 
surgery (scenario 5). All providers can remain 
in the room during an aerosol-generating 
medical procedure (AGMP) and do not need 
to wait any specified time after an AGMP 
before allowing entry into the room or exiting 
a location.10  
3.4 Operating Room Theater 
 Operating room (OR) for patients with 
suspected/confirmed COVID-19 should differ 
from normal OR. The most important is to 
ensure that the airborne particle does not leak 
out of the rooms with COVID-19-infected 
patients. It should be designed starting from 
the protocol for patient flow to and from the 
OR. An OR with negative pressure or neutral 
is preferred to prevent any spread of infection 
and protect healthcare workers. The negative 
pressure created by placing 2-3 exhaust fans 
that will drive air out of the room. The OR 
should be located in dedicated buildings for 
COVID, near the COVID ICU, Emergency 
Ward, and Isolation Ward. Only important 
and essentials items should be inside the 
operating room and separated between 
surgical equipment, linen and dressing, and 
anesthesia. Monitors, cables, cautery, 
operation table, etc., should be covered with 
water-resistant and transparent plastic, which 
should be removed from every post-surgery. 
There should be minimum personnel inside 
COVID OR consist: 1) 2 Surgeons (1 if 
feasible); 2) 1 Nurse ; 3) 1 Anaesthesiologist; 
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